The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia-Reference-Cited by-同舟云学术

The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia

Published:2024-08 Issue:8 Volume:33 Page:
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiology and Drug

Author:

Zoega Helga¹²^ORCID,Falster Michael O.¹^ORCID,Gillies Malcolm B.¹^ORCID,Litchfield Melisa¹^ORCID,Camacho Ximena¹^ORCID,Bruno Claudia¹^ORCID,Daniels Benjamin¹^ORCID,Donnolley Natasha¹^ORCID,Havard Alys¹³^ORCID,Schaffer Andrea L.¹⁴^ORCID,Chambers Georgina⁵^ORCID,Degenhardt Louisa³^ORCID,Dobbins Timothy¹^ORCID,Gisev Natasa³^ORCID,Ivers Rebecca¹^ORCID,Jorm Louisa⁵^ORCID,Liu Bette¹^ORCID,Vajdic Claire M.⁶^ORCID,Pearson Sallie‐Anne¹^ORCID

Affiliation:

1. School of Population Health, Faculty of Medicine and Health UNSW Sydney Sydney Australia

2. Centre of Public Health Sciences, Faculty of Medicine University of Iceland Reykjavík Iceland

3. National Drug and Alcohol Research Centre, Faculty of Medicine and Health UNSW Sydney Sydney Australia

4. The Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences University of Oxford Oxford UK

5. Centre for Big Data Research in Health, Faculty of Medicine and Health UNSW Sydney Sydney Australia

6. The Kirby Institute, Faculty of Medicine and Health UNSW Sydney Sydney Australia

Abstract

ABSTRACTBackgroundThe Medicines Intelligence (MedIntel) Data Platform is an anonymised linked data resource designed to generate real‐world evidence on prescribed medicine use, effectiveness, safety, costs and cost‐effectiveness in Australia.ResultsThe platform comprises Medicare‐eligible people who are ≥18 years and residing in New South Wales (NSW), Australia, any time during 2005–2020, with linked administrative data on dispensed prescription medicines (Pharmaceutical Benefits Scheme), health service use (Medicare Benefits Schedule), emergency department visits (NSW Emergency Department Data Collection), hospitalisations (NSW Admitted Patient Data Collection) plus death (National Death Index) and cancer registrations (NSW Cancer Registry). Data are currently available to 2022, with approval to update the cohort and data collections annually. The platform includes 7.4 million unique people across all years, covering 36.9% of the Australian adult population; the overall population increased from 4.8 M in 2005 to 6.0 M in 2020. As of 1 January 2019 (the last pre‐pandemic year), the cohort had a mean age of 48.7 years (51.1% female), with most people (4.4 M, 74.7%) residing in a major city. In 2019, 4.4 M people (73.3%) were dispensed a medicine, 1.2 M (20.5%) were hospitalised, 5.3 M (89.4%) had a GP or specialist appointment, and 54 003 people died. Anti‐infectives were the most prevalent medicines dispensed to the cohort in 2019 (43.1%), followed by nervous system (32.2%) and cardiovascular system medicines (30.2%).ConclusionThe MedIntel Data Platform creates opportunities for national and international research collaborations and enables us to address contemporary clinically‐ and policy‐relevant research questions about quality use of medicines and health outcomes in Australia and globally.

Funder

National Health and Medical Research Council

National Heart Foundation of Australia

Cancer Institute NSW

NSW Health

University of New South Wales

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5887

Reference36 articles.

1. The changing face of Australian data reforms: Impact on pharmacoepidemiology research

2. Generating Real-World Evidence on the Quality Use, Benefits and Safety of Medicines in Australia: History, Challenges and a Roadmap for the Future

3. Health and Care Data: Approaches to Data Linkage for Evidence‐Informed Policy;Panteli D. P. K.;Health Systems in Transition,2023

4. Productivity Commission “Data Availability and Use ” Report No. 82 2017 accessed September 25 2023https://www.pc.gov.au/inquiries/completed/data‐access/report/data‐access.pdf.